BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25165114)

  • 21. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
    Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
    PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
    Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.
    Almeida RR; Rosa DS; Ribeiro SP; Santana VC; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
    PLoS One; 2012; 7(9):e45267. PubMed ID: 23028895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S; Sutton J; Ariyoshi K; Dong T; Gotch F; McAdam S; Whitby D; Sabally S; Gallimore A; Corrah T
    Nat Med; 1995 Jan; 1(1):59-64. PubMed ID: 7584954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.
    De Groot AS; Jesdale B; Martin W; Saint Aubin C; Sbai H; Bosma A; Lieberman J; Skowron G; Mansourati F; Mayer KH
    Vaccine; 2003 Oct; 21(27-30):4486-504. PubMed ID: 14505932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class I binding regions of HIV-1 proteins.
    Choppin J; Guillet JG; Lévy JP
    Crit Rev Immunol; 1992; 12(1-2):1-16. PubMed ID: 1384546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides.
    Hò GT; Hiemisch W; Pich A; Behrens GMN; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.
    Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
    AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct identification of HLA-presented CD8 T cell epitopes from transmitted founder HIV-1 variants.
    Hare J; Macharia G; Yue L; Streatfield CL; Hunter E; Purcell A; Ternette N; Gilmour J
    Proteomics; 2021 Sep; 21(17-18):e2100142. PubMed ID: 34275180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting Edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication.
    Tomiyama H; Fujiwara M; Oka S; Takiguchi M
    J Immunol; 2005 Jan; 174(1):36-40. PubMed ID: 15611225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.
    Rucevic M; Kourjian G; Boucau J; Blatnik R; Garcia Bertran W; Berberich MJ; Walker BD; Riemer AB; Le Gall S
    J Virol; 2016 Oct; 90(19):8605-20. PubMed ID: 27440904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
    van Stigt Thans T; Akko JI; Niehrs A; Garcia-Beltran WF; Richert L; Stürzel CM; Ford CT; Li H; Ochsenbauer C; Kappes JC; Hahn BH; Kirchhoff F; Martrus G; Sauter D; Altfeld M; Hölzemer A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.